Susquehanna Fundamental Investments’s Transmedics TMDX Stock Holding History

Susquehanna Fundamental Investments’s Portfolio TMDX Stock Details TMDX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-10,121	Closed	-$625K	–	1104
2022 Q4	$625K	Hold	10,121	–	–	0.01%	797
2022 Q3	$422K	Buy	+10,121	New	+$440K	0.01%	1066
2022 Q1	$820K	Buy	30,432 +10,121	+50%	+$181K	0.02%	910
2021 Q4	$389K	Sell	20,311 -4,000	-16%	-$100K	0.01%	1020
2021 Q3	$804K	Buy	+24,311	New	+$743K	0.01%	971

Other funds holding TMDX

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Lord, Abbett & Co Jersey City, New Jersey $30.6B AUM 57.44% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

FAM

Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return

DCM

Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return

SCP

Sandhill Capital Partners Buffalo, New York $1.16B AUM 12.37% 1-Year Est. Return

Allspring Global Investments Charlotte, North Carolina $59.7B AUM 29.08% 1-Year Est. Return

SPPAM

Summit Partners Public Asset Management Boston, Massachusetts $3.72B AUM 162.29% 1-Year Est. Return

Susquehanna Fundamental Investments's TMDX Position: Q1 2023 in Review

Susquehanna Fundamental Investments sold out of Transmedics (TMDX) in Q1 2023, closing a stake of 10,121 shares — an estimated $625K sold.

Susquehanna Fundamental Investments first reported a position in TMDX in Q3 2021 and held it in 5 quarters. The position peaked at $820K in Q1 2022. 224 funds tracked by Wall St. Rank hold TMDX as of Q1 2023.

Susquehanna Fundamental Investments reported no remaining Transmedics position as of Q1 2023 after selling out during the quarter.
Susquehanna Fundamental Investments sold 10,121 Transmedics shares in Q1 2023, an estimated $625K.
Susquehanna Fundamental Investments first reported a position in Transmedics in Q3 2021 and held it in 5 quarters.
Susquehanna Fundamental Investments's Transmedics position peaked at $820K in Q1 2022.
224 funds tracked by Wall St. Rank held Transmedics as of Q1 2023.

Based on Susquehanna Fundamental Investments's 13F filing for Q1 2023, filed 16 May 2023.